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Abstract 
Background: E-cigarettes are the most popular aid to smoking cessation attempts in England and the USA. This 
research examined associations between e-cigarette device characteristics and patterns of use, tobacco-smoking 
relapse, and smoking abstinence.
Methods: A convenience sample of 371 participants with experience of vaping, and tobacco-smoking abstinence 
and/or relapse completed an online cross-sectional survey about e-cigarettes. Factors associated with smoking 
relapse were examined using multiple linear and logistic regression models.
Results: Most participants were self-reported long-term abstinent smokers (86.3%) intending to continue vaping. 
Most initiated e-cigarette use with a vape pen (45.8%) or cig-a-like (38.7%) before moving onto a tank device (89%). 
Due to missing data, managed through pairwise deletion, only around 70 participants were included in some of the 
main analyses. Those using a tank or vape pen appeared less likely to relapse than those using a cig-a-like (tank vs. cig-
a-like OR = 0.06, 95% CI 0.01–0.64, p = 0.019). There was an inverse association between starting self-reported e-ciga-
rette liquid nicotine concentration and relapse, interacting with device type (OR = 0.79, 95% CI 0.63–0.99, p = 0.047), 
suggesting that risk of relapse may have been greater if starting with a low e-cigarette liquid nicotine concentration 
and/or cig-a-like device. Participants reported moving from tobacco-flavored cig-a-likes to fruit/sweet/food flavors 
with tank devices.
Conclusions: Knowledge of how people have successfully maintained tobacco-smoking abstinence using vaping 
could help other tobacco smokers wishing to quit tobacco smoking through vaping.
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Background
E-cigarette use, known as “vaping,” is thought to be less 
harmful than tobacco smoking [1] and e-cigarettes are 
the most popular aid to smoking cessation attempts 
in England [2] and the USA [3]. Estimated current 
e-cigarette use prevalence among tobacco smokers in the 
UK is 21.9%, and 36.5% report ‘ever use’ [4]. In the USA, 
15.9% report current use and 47.6% ever use [5]. Regular 
(at least weekly) e-cigarette use among never smokers in 
Great Britain has been very rare (< 1%) [4] and past week 
vaping by never-smoking adolescents in the USA was 3% 
in a 2018 survey [6].
E-cigarettes are electronic devices that heat “e-liquid” 
(usually comprised of propylene glycol and glycerol, with 
or without nicotine and flavors) stored in a disposable/
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refillable cartridge/reservoir to form an aerosol for inha-
lation [7]. E-cigarettes are commonly referred to as being 
first, second, or third generations (Fig.  1). First-gener-
ation devices are typically “cig-a-likes” designed to look 
and feel like tobacco cigarettes and use prefilled car-
tridges [8]. Second-generation devices generally appear 
like pens, use tanks that can be re-filled and have larger 
battery capacity. Third-generation devices use re-fillable 
tanks and allow modifications to the voltage and/or watt-
age output, improving performance and allowing a tai-
lored user experience. Pod devices, designed to combine 
the simplicity of cig-a-likes with the user experience of 
third-generation devices, were released onto the market 
in the USA in 2015 and subsequently became available in 
the UK [4].
Use of e-cigarettes has grown rapidly and may sup-
port smoking cessation, but there is little evidence on 
long-term health effects or sustained smoking cessa-
tion. A Cochrane review [7] identified two randomized 
controlled trials (RCTs) [9, 10] suggesting e-cigarettes 
are more effective for smoking cessation compared 
with placebo e-cigarettes and one RCT found no sig-
nificant differences between e-cigarettes and nicotine 
patch. However, overall evidence was low quality. Two 
large RCTs have been published since completion of 
this Cochrane review. An RCT comparing provision of 
free cartridge e-cigarettes with low nicotine delivery, 
compared with nicotine patches, suggested a similar 
low efficacy for both treatments (1% and 0.5% sustained 
abstinence at 6  months respectively) [11]. An RCT 
comparing a group assigned to an e-cigarette starter 
pack (second-generation refillable e-cigarette, one bot-
tle of 18 mg e-liquid and recommendations to purchase 
further liquid of their choice) and a group assigned to 
nicotine replacement therapy (NRT) of their choice, 
both with associated behavioral support, found 18.8% 
1 year biochemically verified smoking abstinence in 
the e-cigarette group compared with 9.9% in the NRT 
group (RR 1.83; 95% CI 1.30–2.58, p < 0.001) [12].
Most attempts at smoking cessation result in relapse, 
and smokers generally make multiple quit attempts 
before succeeding [13]. Qualitative research suggests 
e-cigarettes can meet many of the needs of ex-smokers 
by substituting physical, psychological, social, cultural 
and identity-related aspects of tobacco addiction [14, 
15]. According to a time-series analysis of data from 
the Smoking Toolkit study, in which repeated cross-
sectional surveys are conducted with a representative 
sample of households in England, increasing prevalence 
of e-cigarette use in current smokers was predictive of 
higher success rates of quit attempts [16].
There is evidence that how people use e-cigarettes, 
in terms of device type and patterns of use, can affect 
number and success rate of quit attempts. Brose et  al. 
found that daily, but not non-daily, e-cigarette use is 
predictive of greater cigarette cessation attempts and 
reduced smoking among UK adults [17]. Evidence sug-
gests abstinence from smoking may be significantly 
higher among tank users [18]. Another determining 
factor in e-cigarette effectiveness is the nicotine con-
centration used. The amount of nicotine delivered 
varies depending on a range of characteristics, includ-
ing the device (e.g., model, wattage), e-liquid (e.g., fla-
vor, ingredients, pH) and user behaviour (e.g., puffing 
topography) [19, 20]. A Cochrane review of NRT for 
smoking cessation suggested heavier smokers required 
higher nicotine doses [21]. According to an ethno-
graphic study, vape shops recommend higher e-liquid 
nicotine concentrations for heavier smokers [22], but 
this is not yet backed up by robust evidence.Fig. 1 Examples of first-, second-, and third-generation e-cigarettes
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Current understanding of how e-cigarette users, known 
as “vapers,” use e-cigarettes to avoid smoking relapse, is 
limited. This study reports results of an online survey 
from a convenience sample of vapers to elucidate pat-
terns of use and types of devices that might best support 
ongoing tobacco-smoking abstinence. Hypotheses were 
generated based on the associated qualitative study [15]. 
We hypothesized:
1 Those who initiate vaping using a first-generation 
device are more likely to relapse to tobacco smoking 
than those initiating using a later-generation device;
2 Those who start on a low self-reported nicotine 
e-liquid concentration (strength) will be more likely 
to relapse to tobacco smoking than those starting on 
a higher nicotine e-liquid, after controlling for ciga-
rettes per day (CPD) before cessation;
3 There will be a relationship between lower nicotine 
strength, interacting with device type, and relapse, as 
newer-generation devices provide nicotine more effi-
ciently [23].
Methods
Participants
A convenience sample of UK vapers were invited to par-
ticipate in an online survey, combining fixed choice and 
open-ended responses, collecting quantitative and quali-
tative data. This paper reports analyses of the quantita-
tive data collected.
Participants who self-reported a history of tobacco 
smoking, experience of using an e-cigarette and tobacco-
smoking abstinence or relapse following e-cigarette use, 
were initially recruited to participate in a qualitative 
study [15, 24]. When the qualitative study reached “sat-
uration,” further volunteers were diverted to the survey. 
Recruitment was through word of mouth, press articles, 
university bulletins, and social media.
Procedure
Informed consent was obtained. Question items were 
designed based on topics from the accompanying quali-
tative study. Questions were asked on socio-demographic 
characteristics, tobacco variables, e-cigarettes and pre-
vious quit attempts. Data on relapse were obtained by 
asking participants whether they were abstinent from 
smoking after using their first device (“yes” or “no, I 
relapsed”). For data on e-cigarette device use, we asked 
“What type of e-cigarette device did you try first? Please 
select the picture that looks most like the device you 
started with”, “Did your first device help you stay stopped 
from smoking tobacco?” and “What type of e-cigarette 
device do you currently use the most?”.
There were two versions of the survey which were com-
bined for analysis. One of the questions from Version 1 
(V1 n = 183) on devices used was poorly completed and 
complex and was re-designed for Version 2 (V2 n = 188). 
V1 asked participants to list devices they have used in the 
order they used them, starting with the first one tried to 
the one currently used. Free-text boxes were provided for 
the device name, wattage, nicotine strength (e.g., 12 mg, 
6 mg) and flavorings (e.g., tobacco, fruit). V2 asked par-
ticipants to select the type of device they tried first and 
the device used currently in a multiple-choice question 
including cig-a-like, vape pen, mod and tank, and other. 
Options were accompanied by an example photo. They 
were then asked to detail in free text boxes their cur-
rent and starting flavor (e.g., tobacco, fruit) and nicotine 
strength. Free text responses on device type from V1 
were coded as per the categories for V2 and included in 
this analysis. Data described below includes participants 
from both versions.
The study received ethical approval from the University 
of East Anglia Faculty of Medicine and Health Sciences 
Research Ethics Committee.
Analysis
Participant characteristics, tobacco and e-cigarette vari-
ables were examined with descriptive statistics. Binary 
logistic regression was used to examine associations 
between device type or nicotine strength and current/
previous self-reported relapse. Relapse was defined as 
“a successful smoking quit attempt of at least 48  h, fol-
lowed by a relapse (more than five instances of smoking) 
to tobacco smoking.” This was chosen in order to cap-
ture both early and late relapsers, whilst excluding dual 
users and triallers (those who use e-cigarettes alongside 
tobacco smoking without making a serious quit attempt). 
Five episodes were required for relapse as per the Russell 
Standards which allow up to five cigarettes to be smoked 
for an individual still to be considered smoking abstinent 
[25]. After examining these associations, the interaction 
between device type and strength and its possible asso-
ciation with relapse was investigated by adding an inter-
action term for strength and device to the model.
Multiple linear regression was used to examine asso-
ciations between CPD and e-liquid nicotine starting 
strength.
Missing data were dealt with through pairwise dele-
tion in order to increase power. Where percentages are 
reported in the results section, this is the percentage of 
those for whom there were data available for that varia-
ble. Here “n” is used in the results section this is the abso-
lute number of participants who gave that response, so 
where there is missing data this will not total 371.
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All models were built up stepwise, controlling for age 
and sex, followed by CPD.
In the results section, descriptive statistics are pre-
sented, followed by the results for each of the three 
hypotheses tested.
Results
Descriptive statistics
509 participants entered the online survey (V1 n = 249, 
V2 n = 260). Of these, 27.1% did not give consent to 
participate and were discarded (V1 n = 66, V2 n = 72), 
leaving 371 participants (V1 n = 183; V2 n = 188). Of 
these 371 participants’ the number of responses to indi-
vidual questions varied. Questions on flavors, device 
types, e-liquid nicotine strengths and vaping status were 
answered by more than 60% of the 371 participants. 
Questions on smoking status were answered by 56.9% 
of participants. Questions on relapse, the main outcome 
variable, were only answered by 42% of participants. 
Sample sizes for key outcomes are presented in Fig. 2.
Demographic characteristics
23.6% of participants were female and mean age was 49 
(SD 11.61, range 22–78). Participants came from across 
the UK. Eight participants (< 1%) reported living outside 
of the UK.
Half of participants (50.0%) were married 
(n = 108/216), 26.4% were single (n = 57/216), 14.8% were 
cohabiting (n = 32/216), 6.0% were divorced (n = 13/216) 
and 2.7% were widowed (n = 6/216).
92.3% (n = 84/91) described themselves as “White”, 
10.7% (n = 9/91) of whom specified “White European”. 
The remainder were “Mixed” (n = 6/91) or “Asian” 
(n = 1/91).
Regarding occupation, 24.1% (n = 39/162) described 
themselves as “retired” and 6.2% (n = 10/162) “self-
employed”. The remaining 69.7% of participants were 
in work (n = 113/162) and were classified accord-
ing to the NRS Social Grade classification. Of those in 
work, 19.1% (n = 22/113) were social grades A and B, 
47.6% (n = 53/113) social grades C1 and C2 and 33.3% 
(n = 38/113) grades D and E.
Smoking and vaping status
Most participants were long-term abstinent from 
tobacco smoking (defined as ≤ 5 instances of one-off 
tobacco-smoking relapse in the last 12  months) (86.3%, 
n = 182/211), > 99% of whom continued to vape. A fur-
ther 10.4% had recently quit smoking and were vap-
ing (n = 22/211) and 3.1% (n = 7/211) were vaping and 
occasionally smoking. Most intended to continue vap-
ing (85.4%, n = 194/227). < 1% had already stopped using 
e-cigarettes.
Of those still using e-cigarettes (n = 256), the average 
reported duration of use was 3.9  years (SD 2.3, range 
1 month to 9.8 years).
Participants entered 
online questionnaire
Version 1 (n=249)
Participants entered 
online questionnaire
Version 2 (n=260)
Participants consented 
to participate (n=183)
Participants consented 
to participate (n=188)
Did not 
consent V1 
(n=66)
Did not 
consent V2 
(n=249)
Total participants in online questionnaire (n=371)
Included participants for main analyses (reduced due to missing data): 
Device type and relapse n=79
Starting strength and CPD n=192
Starting strength, interacting with device type, and relapse n=72
Fig. 2 Survey participant flow diagram
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Self‑reported e‑liquid nicotine concentration (strength) used
Mean initial nicotine strength was 19.84  mg (SD 8.97, 
range 0–48  mg), reducing to an average 7.96  mg with 
their current device (SD 7.06, range 0–36  mg). Higher 
mean CPD generally appeared to coincide with higher 
starting strength, except in the group starting with 
0-6 mg nicotine e-liquid (Table 1).
Self‑reported e‑liquid flavors used
Results suggest a change in flavor choices over the course 
of vaping initiation and uptake. There was a reduction in 
the proportion of people using a tobacco flavor (− 36.5%, 
95% CI − 43.5 to − 29.6), and increase in the proportion 
using a fruit/sweet/food flavor (+ 31.7%, 95% CI 23.3–
40.0%), from initial to current flavor choice (Additional 
file 1: Table A1).
Self‑reported devices used
Most participants reported their initial device was either 
a vape pen (second generation) (45.8%) or cig-a-like (first 
generation) (38.7%). Most reported their current device 
to be a mod and tank (third generation) (89.4%).
No differences in demographic characteristics of those 
who chose different initial devices were identified (Addi-
tional file 1: Table A2).
Among those who became successfully abstinent 
from smoking using their first device (44.9%, n = 71), 
71.8% (n = 51) switched to another device, all of whom 
moved from an earlier to later-generation device. Of 
those who became successfully abstinent from smok-
ing using their first e-cigarette device and continued to 
use the same or a similar type of device (n = 20), 65.0% 
(n = 13) had started with a mod and tank device, 24.0% 
(n = 5) a vape pen and only two successfully stopped 
smoking with, and continued to use, a cig-a-like.
Coded self-reported reasons as to why participants 
moved on from their first device indicate that most 
wished to upgrade to a device they perceived as better 
(n = 57) or to move on from a device they considered 
inadequate for their needs (n = 21) due to battery life/
power, flavor and improved technology. Some wished 
to upgrade to enjoy opportunities to personalize their 
device or as a hobby (Additional file 1: Table A3). Mean 
number of devices tried was 5.4 (SD 2.96, range 1–15, 
n = 98).
Results for hypothesis 1
Hypothesis 1 Those who initiate vaping using a first-
generation device are more likely to relapse to tobacco 
smoking than those initiating using a later-generation 
device.
Only 44.9% (n = 71/158) reported successful tobacco 
abstinence after using their first device. 24.7% 
(n = 39/158) reported dual use, 18.4% (n = 29/158) 
full relapse and 12.0% (n = 19/158) occasional lapses. 
Relapse appeared more common among those using a 
cig-a-like, compared with a vape pen or a mod and tank 
(Table 2).
Those using a mod and tank device (n = 16/98), or a 
vape pen (n = 40/98), on initiation were significantly less 
likely to relapse than those using a cig-a-like (n = 42/98) 
(mod and tank vs. cig-a-like OR = 0.06, 95% CI 0.01–0.50, 
p = 0.009; vape pen vs. cig-a-like OR = 0.16, 95% CI 0.06–
0.46, p = 0.001, n = 98). This difference remained after 
controlling for age and sex (mod and tank vs. cig-a-like 
OR = 0.06, 95% CI 0.01–0.64, p = 0.019; vape pen vs. cig-
a-like OR = 0.14, 95% CI 0.04–0.51, p = 0.003, n = 79).
Table 1 Starting e-liquid nicotine strengths and cigarettes 
per day
a Note only a single participant reported using 0 mg/ml as a starting e-liquid 
nicotine concentration
Starting strength (mg) Participants (n = 200) Mean CPD
0–6a 21 28.3
7–12 25 23.8
13–18 67 28.2
19–24 57 30.5
25+ 30 36.8
Table 2 Device types and relapse
a Note percentages do not total exactly 100 due to rounding
Device type Initial device type (n = 238) Relapse with initial device (n = 98 asked and responded 
to this question)
Final 
device type 
(n = 235)
Cig-a-like 92 (38.66%)a 22/42 (52.38%) 3 (1.28%)
Vape pen 109 (45.80%) 6/40 (15%) 22 (9.36%)
Mod and tank 38 (16.00%) 1/16 (6.25%) 210 (89.36%)
All 238 29/98 (29%) 235
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Results for hypothesis 2
Hypothesis 2 Those who start on a low self-reported 
nicotine e-liquid concentration (strength) will be more 
likely to relapse to tobacco smoking than those starting 
on a higher nicotine e-liquid, after controlling for ciga-
rettes per day (CPD) before cessation.
Mean initial nicotine strength was 19.84  mg (SD 8.97, 
range 0–48 mg) and mean current nicotine strength was 
7.96 mg (SD 7.06, range 0–36 mg), suggesting most par-
ticipants reduced nicotine strength over time.
Splitting data on initial e-liquid nicotine strengths into 
quartiles suggested those with higher reported CPD may 
use higher starting strengths. A simple linear regres-
sion was calculated to predict starting nicotine strength 
based on CPD. A significant association was found, with 
nicotine strength increasing by 0.1  mg for every extra 
cigarette smoked per day (95% CI 0.025–0.187, p = 0.01, 
n = 200). The strength of the association reduced slightly 
but remained statistically significant after controlling 
for age and sex (0.08  mg increase, 95% CI 0.003–0.164, 
p = 0.041, n = 192).
There was no association between initial self-reported 
e-liquid nicotine content and relapse (OR = 1.00, 95% 
CI 0.95–1.05, p = 0.895, n = 100) and there continued to 
be no association after controlling for age, sex, device 
type and CPD (OR = 1.01, 95% CI 0.95–1.09, p = 0.677, 
n = 72).
Results for hypothesis 3
Hypothesis 3 There will be a relationship between 
lower nicotine strength, interacting with device type, and 
relapse, as newer-generation devices provide nicotine 
more efficiently [20].
After adding an interaction term for initial strength and 
device type, there was a small but statistically significant 
inverse association between starting strength and relapse 
(OR = 0.79, 95% CI 0.63–0.99, p = 0.047, n = 72). There 
was a significant interaction term for the device type and 
nicotine strength interaction (OR = 1.18, 95% CI 1.02–
1.37, p = 0.026, n = 72).
Discussion
This study of real-world patterns of e-cigarette use sug-
gests choice of products and liquids may impact tobacco-
smoking relapse.
Relapse was much more likely among people initiat-
ing e-cigarette use with a cig-a-like, compared with 
other types of device. According to an ethnographic 
study, vape shops sometimes separate devices into 
“beginner,” “intermediate,” and “advanced” in displays 
[22]. Cross-sectional surveys by McNeill et  al. sug-
gested newer e-cigarette designs were more effective 
for smoking cessation (38.0%) than older ones(19.9%) 
[18, 26]. A study of 50 smokers unwilling to quit who 
were provided with second-generation e-cigarettes 
found 36% CO verified smoking abstinence after 
24 weeks [27]. An online survey by Etter suggested that 
users perceived tank devices as more effective than 
pre-filled models for smoking cessation [28]. Our study 
supports these findings but classified devices into three 
categories (cig-a-like, vape pen and tank), providing 
additional granularity. As our data is cross-sectional, 
it is unclear whether progressing from a simpler device 
to a more complex one is beneficial, such as allowing 
the user to develop skills in adapting their device to suit 
their needs, or if new users should be recommended to 
start with a newer device.
Most shops in an ethnographic study of vape shops 
used “rules of thumb” when recommending nicotine 
strengths to customers [22]. Smokers of ≤ 10 CPD are 
recommended 3–6  mg nicotine, 10–20 CPD 6–12  mg 
and 20+ CPD 18  mg. Our results suggest that in prac-
tice vapers who reported higher CPD generally start with 
higher nicotine strength e-liquids, but that perhaps some 
smokers are starting on strengths insufficient for their 
needs. Mean CPD for those starting on 0–6  mg nico-
tine was 28.3, much higher than the 10 CPD advised by 
vape shops (Table 2). Mean initial nicotine strength was 
19.84 mg (SD 8.97, range 0–48 mg), reducing to an aver-
age 7.96  mg with their current device (SD 7.06, range 
0–36 mg). The upper limit of nicotine in e-liquid in Eng-
land is 20 mg/mL, and the maximum tank capacity 2 mL, 
as of May 2016, with a transition period until May 2017. 
The upper reported strength of 48  mg is beyond this 
limit, perhaps as they initiated vaping prior to transition 
or outside England, or due to errors in recall.
This study supports others suggesting vapers decrease 
their e-liquid nicotine strength over time [29–31], 
although those studies suggest users compensate for this 
by changing puffing patterns and using more e-liquid, 
maintaining cotinine levels. Research has shown that nic-
otine delivery is a function of device power, e-liquid nico-
tine concentration, and topography. Our study suggests 
participants may be transitioning from cig-a-likes with 
lower power and higher nicotine e-liquid concentrations 
to mod and tank devices with greater power and lower 
e-liquid nicotine concentrations. Whilst self-reported 
e-liquid nicotine concentration decreased, users may be 
taking in similar/more nicotine from these later-gener-
ation devices than the low power/high nicotine devices 
that have been shown to deliver nicotine poorly. We 
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cannot tell from this study how nicotine intake changes 
over time.
This study reports novel findings suggesting starting 
on insufficient levels of nicotine based on previous CPD, 
combined with a less powerful device, may lead to greater 
risk of relapse. Sample size for that analysis was only 72, 
so further exploration of this hypothesis with a larger 
sample size, allowing for the inclusion of more confound-
ers within the model, is warranted.
According to the 2017 ASH-A survey, among cur-
rent users, fruit flavors were the most popular (28.5%), 
followed by tobacco (26.9%) and menthol/mint flavors 
(25.3%) [1]. Previous studies suggested fruit-flavored 
e-liquids are more popular among young people [31]. 
Our results suggest a change in flavor choices over time. 
We saw a significant reduction in use of tobacco flavor 
and increases in use of fruit/sweet/food flavors from ini-
tial to current flavor choice. An online survey by Russell 
et al. in the USA reported that initiating e-cigarette use 
with a tobacco-flavored e-liquid became less common 
between pre-2011 and 2015/16, and sweet flavors became 
more common [32]. Litt et al. report that among smokers 
asked to vape for 6 weeks, those given a menthol/tobacco 
flavor smoked less than those given cherry/chocolate 
[33]. Longitudinal surveys are required to see whether 
changing flavor over time, as well as flavor choice at initi-
ation, might be beneficial to sustained smoking cessation. 
Preferences for fruit/sweet/food flavors may have impli-
cations for areas where flavors are banned [34].
Limitations
This study is cross-sectional and so cannot identify caus-
ative associations. It relied on retrospective reports of 
vaping practices which may be subject to recall bias. Data 
on cessation were self-reported and not biochemically 
verified.
Another major limitation is missing data. Questions on 
flavors, device types, e-liquid nicotine concentration and 
vaping status were answered by more than 60% of partici-
pants, but questions on smoking status were answered by 
56.9% of participants and questions on relapse, the main 
outcome variable, were only answered by 42% of partici-
pants. Many participants did not complete all questions, 
meaning some analyses are underpowered and some 
potential confounders could not be included in regres-
sion models. Pairwise deletion was used to manage miss-
ing data instead of multiple imputation, which may have 
been a more robust approach [35].
This survey recruited a convenience sample of e-ciga-
rette users, likely representing those who were success-
ful and wished to share their experiences. While not 
representative of the wider population of vapers, it does 
suggest ways in which smokers who have successfully 
switched to vaping may have achieved this successful 
transition.
Demographic characteristics of participants in this sur-
vey were compared with those of Smoking Toolkit Study 
participants who smoked cigarettes or any other tobacco 
product daily or occasionally at the time of the survey or 
during the preceding 12 months (Table 3) [36]. This sug-
gested our sample were more likely to be of higher social 
grade and the percentage of female participants is much 
lower, which may be related to the perceived masculinity 
of vaping [22]. Mean reported CPD before cessation was 
33.8 in this study, much higher than the 2015 UK average 
of 11.3 [36].
Weaver et  al. highlight the variations in terminol-
ogy (e.g., e-cigarette, vaping) and device descriptions 
(e.g. mod, personal vaporizer) among consumers and 
researchers [37]. This survey attempted to overcome 
these challenges by permitting participants to describe 
devices in their own words, but this was poorly com-
pleted, and the survey had to be adapted to a multiple-
choice option.
None of the survey participants reported using Pod 
devices as these were not commonly used in the UK 
when the survey was conducted and so we are unable 
to comment on the potential role of these devices. Fur-
ther research is needed into the effectiveness of these 
devices for sustained smoking cessation as their popular-
ity grows.
Future research
There is a need for studies on relapse to smoking among 
e-cigarette users that follow people up over time, pro-
viding data on trajectories, to understand how users 
experience progressing from simpler to more mod-
ern devices. If followed up over a long period, trends 
in e-cigarette use could be assessed, including whether 
people switching to e-cigarettes now or in the future 
Table 3 Comparison of  participant demographics 
with the Smoking Toolkit Study
Smoking Toolkit Study This study (ECtra)
Mean age 39.5 (SD 15.6) 49 (SD 11.61)
Female (%) 54 23.63
Social grade (% in each category)
A 10.7 (A + B) 10.5 (n = 17)
B 8.6 (n = 14)
C1 22.9 38.3 (n = 62)
C2 22.7 9.3 (n = 15)
D 18.8 15.4 (n = 25)
E 24.8 17.9 (n = 29)
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are more likely to use a more modern device and so 
need a lower nicotine strength. Studies may consider 
how those switching from tobacco could be supported 
to choose a suitable device and strength, perhaps 
through working with vape shops and online retailers.
Future research could explore the potential role of 
flavors in relapse. Qualitative studies have suggested 
that perceiving e-cigarettes as something very differ-
ent from tobacco smoking, rather than a substitute, 
is important for some vapers in avoiding a return to 
smoking [15]. The results of this study suggest a tran-
sition over time away from devices that look and feel 
like tobacco cigarettes, but further research is needed 
to investigate associations between e-liquid flavor and 
tobacco-smoking relapse.
Conclusions
The results of this study suggest the choice of e-ciga-
rette products and liquids used may have an impact 
on relapse to tobacco smoking. Those initiating vaping 
with a less sophisticated device and/or lower nicotine 
strength e-liquid may be at higher risk of relapse to 
tobacco smoking. Self-report patterns of device use by 
vapers suggest changing patterns over time, with many 
users moving from less sophisticated, tobacco-flavored 
cig-a-like devices, to more sophisticated tank devices 
with fruit/sweet/food flavors.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
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